SCHEMBL23309492

SCHEMBL23309492

Cc1ccc(NC(=O)c2cc(F)nc(F)c2F)cc1Br

nearest known ligand 0.48

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 5/20 0.45
▸ NPC1 O15118 4/20 0.45
▸ SMN1; SMN2 Q16637 2/20 0.45
▸ ALDH1A1 P00352 4/20 0.41
▸ HSD17B10 Q99714 1/20 0.41
▸ LMNA P02545 2/20 0.41
▸ KDM4E B2RXH2 2/20 0.40
▸ CYP1A2 P05177 1/20 0.40
▸ GPR27 Q9NS67 1/20 0.40
▸ TDP1 Q9NUW8 1/20 0.40
▸ MEN1 O00255 2/20 0.39
▸ KMT2A Q03164 2/20 0.39
▸ GAA P10253 1/20 0.39
▸ MAPT P10636 1/20 0.39
▸ POLB P06746 1/20 0.39
▸ PKM P14618 1/20 0.39
▸ SNCA P37840 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23309483 0.88 CYP1A2 (0.52) RAB9ANPC1SMN1; SMN2ALDH1A1HSD17B10
SCHEMBL23309702 0.87 ALDH1A1 (0.55) RAB9ANPC1SMN1; SMN2ALDH1A1HSD17B10
SCHEMBL23309566 0.85 ALDH1A1 (0.41) RAB9ANPC1SMN1; SMN2ALDH1A1HSD17B10
SCHEMBL23309539 0.85 NPC1 (0.52) RAB9ANPC1SMN1; SMN2ALDH1A1HSD17B10
SCHEMBL23309533 0.84 ALDH1A1 (0.43) RAB9ANPC1SMN1; SMN2ALDH1A1HSD17B10
SCHEMBL23309730 0.83 KMT2A (0.47) RAB9ANPC1SMN1; SMN2ALDH1A1LMNA
SCHEMBL23309715 0.82 SORT1 (0.46) RAB9ANPC1SMN1; SMN2LMNAMEN1
SCHEMBL23309711 0.82 GRM4 (0.53) RAB9ANPC1SMN1; SMN2ALDH1A1KDM4E
SCHEMBL23309621 0.82 RAB9A (0.50) RAB9ANPC1SMN1; SMN2ALDH1A1HSD17B10
SCHEMBL23309703 0.80 RAB9A (0.51) RAB9ANPC1SMN1; SMN2ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210120817-A1 PLANT DISEASE CONTROL AGENT MEIJI SEIKA PHARMA CO., LTD. (JP) 2021-04-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210120817-A1 PLANT DISEASE CONTROL AGENT BROX, ALG1, CTRL RAB9A 286/4885NPC1 412/4885SMN1; SMN2 3893/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback